The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this painful autoimmune skin disease. UCB announced today that the FDA has ...

Data from two Phase 3 studies, BE HEARD I and BE HEARD II, support the approval. On Wednesday, the FDA approved UCB SA ... is a chronic inflammatory skin disease. The main symptoms are nodules ...

Rosacea is a skin condition ... the regulator approved the drug to treat inflammation associated with the condition, and not for reducing redness, also known as erythema. The FDA had a concern ...

The FDA (Food and Drug Administration) recently approved a new product, called ReCell, designed to treat severe burns to the body all with a single spray. Confused? Let’s start from the beginning.

(Reuters) -Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a ...

Acoramidis is the first FDA-approved treatment for ATTR-CM with near-complete TTR stabilization, reducing cardiovascular death and hospitalization. The phase 3 ATTRibute-CM trial showed acoramidis ...

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous ...

MONDAY, Nov. 25, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate-to-severe hidradenitis suppurativa.

12, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride ... "Rosacea is a difficult to treat skin condition, and based on the favorable ...

The FDA has approved a new treatment, Aucatzyl, for a type of aggressive blood cancer called B-cell acute lymphoblastic leukemia (B-cell ALL). This treatment, a CAR T-cell immunotherapy ...

In its second attempt, Takeda has secured FDA approval for Eohilia, which becomes the first and only oral therapy in the US for eosinophilic oesophagitis (EoE). The US regulator has cleared ...